Drawing for DAIICHI-SANKYO

USPTO serial 79137242

DAIICHI-SANKYO

Reviewed by CopyMark Law Group

Reg. 4733605Status 706Registered
Filing date
Status date
Registration date
May 12, 2015
Examiner
BRADLEY, EVELYN
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with DAIICHI-SANKYO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bassam N. Ibrahim

Bassam N. Ibrahim Buchanan Ingersoll & Rooney, PC1737 King Street, Suite 500Alexandria, VA 22314-2727United States

Goods and services

ClassDescriptionStatusFirst use
001[Chemical food preservatives; chemical plasticizers for use as high polymer stabilizers for plastics and paints; synthetic chemical polymer stabilizers for use as light stabilizers for plastics and coatings; chemical additives for use in the manufacture of foods; chemical antioxidants for use in the manufacture of drinks, cakes, flavoring agents, dairy products and fish paste products; chemical germination controllers, namely, gibberellins for grapes, oranges and for domestic and agricultural use; diagnostic reagents for in vitro scientific use; diagnostic preparations for in vitro biological tests, namely, for urine and blood tests, for blood glucose tests, for clotting tests, all for scientific use; enzyme preparations for use in vitro scientific use; soil conditioners, namely, soil improving agents and plant growth regulators for agricultural use; tetrodotoxins for scientific research use; adhesives not for stationery or household purposes; plant growth regulating preparations; fertilizers; higher fatty acid for use as food additive for food manufacturing; chemical test paper; artificial sweeteners]SECTION 71 - CANCELLED—
005Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease; vaccines; diagnostic reagents and contrast media for medical use; [veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens and dysentery in pigs; sanitary preparations for medical use and sanitary preparations for agricultural use, namely, herbicides, fungicides, insecticides, bactericides and rodenticides; oiled paper for medical purposes; facial masks for sanitary purposes, not for medical personnel, namely, masks used for germ, virus, and allergen prevention sold as part of a kit consisting primarily of sanitizing preparations for household use; drug delivery agents in the form of edible wafers for wrapping a dose of powdered medicine, namely, unit dose gelatin or starch based dissolvable thin film sold empty for pharmaceuticals; gauze for dressings; unit dose capsules sold empty for pharmaceuticals; eye patches for medical use; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical use; adhesive plasters for medical use; bandages for dressings; collodion for medical use; breast-nursing pads; dental impression material; dental cements; dental abrasives; dental mastics; lactose for pharmaceutical purposes; powdered milk for babies; dietetic beverages, namely, nutritionally fortified beverages, vitamin fortified beverages and mineral fortified beverages adapted for medical purposes; baby foods; edible plant fibers, namely, dietary fibers for use as non-nutritive additives for food products to aid digestion; ground flaxseed fibers used in dietary supplements]ACTIVE—
042Technical research in the fields of pharmaceutical products, medicines and cosmetics; project studies, namely, research relating to pharmaceutical products, medicines and cosmetics; technical project studies, namely, research relating to pharmaceutical products, medicines and cosmetics; research on civil engineering; research and development for others in the fields of pharmaceutical products, medicines and cosmetics; quality testing in the fields of pharmaceutical products, medicines and cosmetics; quality evaluation of pharmaceutical products, medicines and cosmetics; chemical analysis in the fields of pharmaceutical products, medicines and cosmetics; chemistry services in the nature of chemistry consultation in the fields of pharmaceutical products, medicines and cosmetics; chemical research in the fields of pharmaceutical products, medicines and cosmetics; cosmetic research; bacteriological research relating to pharmaceutical preparations and medicine; biological research relating to pharmaceutical preparations and medicine; product research and development in the fields of medical and pharmaceutical preparations and medicines; research and development relating to manufacturing processes in the fields of medical and pharmaceutical preparations and medicines; research and development, namely, conducting clinical trials for othersACTIVE—
044[Medical clinics; hospitals; health care; medical assistance services; physical therapy; medical nursing services; pharmaceutical advice; plastic surgery; telemedicine services; pharmacists' services to make up prescriptions; veterinary assistance services;] providing healthcare advisory services and information in the fields of pharmaceutical preparations, pharmaceutical products, medicines, medical treatment, diseases and administration of medicines; [preparation] and [dispensing of medications; medical services;] providing information relating to healthcareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 25, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Mar 25, 202671AGREGISTERED-SEC.71 ACCEPTED—
Mar 8, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 3, 2025ES71TEAS SECTION 71 RECEIVED—
May 12, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 22, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Apr 6, 2023INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 6, 2023INPCINVALIDATION PROCESSED—
Feb 14, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 6, 2023RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 14, 2022NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jun 14, 2022C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
May 23, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 11, 2021ES75TEAS SECTION 71 & 15 RECEIVED—
May 12, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 18, 2016CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Mar 18, 2016CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 18, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 3, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 3, 2015FIMPFINAL DISPOSITION PROCESSED—
Aug 12, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 12, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 24, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 24, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 19, 2015GPNXNOTIFICATION PROCESSED BY IB—
Feb 4, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 4, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 4, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 21, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 20, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 16, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 16, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 16, 2015ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 2, 2015GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
Jan 2, 2015GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
Jan 2, 2015CNCFACTION CONTINUING A FINAL - COMPLETED—
Dec 8, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 8, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 1, 2014ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 22, 2014CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 16, 2014CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jun 3, 2014GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 3, 2014GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 3, 2014CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 15, 2014CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 15, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 5, 2014ALIEASSIGNED TO LIE—
Apr 18, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2013RFNTREFUSAL PROCESSED BY IB—
Oct 29, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 29, 2013RFRRREFUSAL PROCESSED BY MPU—
Oct 29, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 28, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 22, 2013DOCKASSIGNED TO EXAMINER—
Oct 22, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 22, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Oct 18, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance